Candel Therapeutics
CADL
CADL
23 hedge funds and large institutions have $34M invested in Candel Therapeutics in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.97% less ownership
Funds ownership: 24.23% → 23.26% (-0.97%)
38% less capital invested
Capital invested by funds: $54.4M → $34M (-$20.4M)
Holders
23
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$382K | |
| 2 | +$90.2K | |
| 3 | +$86K | |
| 4 |
KAS
Kestra Advisory Services
Austin,
Texas
|
+$64K |
| 5 |
EAM
Empirical Asset Management
Wellesley,
Massachusetts
|
+$61K |
Top Sellers
| 1 | -$1.48M | |
| 2 | -$782K | |
| 3 | -$102K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$41.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$12.2K |